2seventy bio, (id:8041 TSVT)
3.61 USD
Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/24/2024 1:29:08 PM)
Exchange closed, opens in 20 hours
14.24 USD (14.24%)
2.27 USD (2.27%)
-27.80 USD (-27.80%)
-21.35 USD (-21.35%)
102.81 USD (102.81%)
-73.78 USD (-73.78%)
About 2seventy bio,
Market Capitalization 212.69M
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company's products pipeline includes Abecma, a chimeric antigen receptor T-cell product candidates for the treatment of multiple myeloma. It has a collaboration arrangement with Bristol Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.
| Headquarters (address) |
60 Binney Street Cambridge 02142 MA United States |
| Phone | 617 675 7270 |
| Website | https://www.2seventybio.com |
| Employees | 274 |
| Sector | Healthcare |
| Industry | Biotechnology |
| Ticker | TSVT |
| Exchange | NASDAQ Stock Exchange |
| Currency | USD |
| 52 week range | 1.68 - 6.40 |
| Market Capitalization | 212.69M |
| P/E trailing | -0.817 |
| P/E forward | -9.60 |
| Price/Sale | 4.82 |
| Price/Book | 0.819 |
| Beta | 1.79 |
| EPS | -3.06 |
| EPS United States (ID:6, base:3402) | 24.22 |